These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
493 related articles for article (PubMed ID: 31499171)
1. Design and characterization of a novel 3D printed pressure-controlled drug delivery system. Krause J; Bogdahn M; Schneider F; Koziolek M; Weitschies W Eur J Pharm Sci; 2019 Dec; 140():105060. PubMed ID: 31499171 [TBL] [Abstract][Full Text] [Related]
3. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets. Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424 [TBL] [Abstract][Full Text] [Related]
4. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing. Alhijjaj M; Belton P; Qi S Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210 [TBL] [Abstract][Full Text] [Related]
5. Printfills: 3D printed systems combining fused deposition modeling and injection volume filling. Application to colon-specific drug delivery. Linares V; Casas M; Caraballo I Eur J Pharm Biopharm; 2019 Jan; 134():138-143. PubMed ID: 30476539 [TBL] [Abstract][Full Text] [Related]
6. An Effective Technology for the Development of Immediate Release Solid Dosage Forms Containing Low-Dose Drug: Fused Deposition Modeling 3D Printing. Gültekin HE; Tort S; Acartürk F Pharm Res; 2019 Jun; 36(9):128. PubMed ID: 31250313 [TBL] [Abstract][Full Text] [Related]
7. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery. Gioumouxouzis CI; Baklavaridis A; Katsamenis OL; Markopoulou CK; Bouropoulos N; Tzetzis D; Fatouros DG Eur J Pharm Sci; 2018 Jul; 120():40-52. PubMed ID: 29678613 [TBL] [Abstract][Full Text] [Related]
8. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability. Solanki NG; Tahsin M; Shah AV; Serajuddin ATM J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279 [TBL] [Abstract][Full Text] [Related]
9. Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets. Sadia M; Sośnicka A; Arafat B; Isreb A; Ahmed W; Kelarakis A; Alhnan MA Int J Pharm; 2016 Nov; 513(1-2):659-668. PubMed ID: 27640246 [TBL] [Abstract][Full Text] [Related]
10. Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing. Goyanes A; Chang H; Sedough D; Hatton GB; Wang J; Buanz A; Gaisford S; Basit AW Int J Pharm; 2015 Dec; 496(2):414-20. PubMed ID: 26481468 [TBL] [Abstract][Full Text] [Related]
11. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets. Zhang J; Feng X; Patil H; Tiwari RV; Repka MA Int J Pharm; 2017 Mar; 519(1-2):186-197. PubMed ID: 28017768 [TBL] [Abstract][Full Text] [Related]
12. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production. Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253 [TBL] [Abstract][Full Text] [Related]
13. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets. Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000 [TBL] [Abstract][Full Text] [Related]
14. Development of 3D-printed dual-release fixed-dose combination through double-melt extrusion. Oh HS; Park JB Int J Pharm; 2024 Aug; 661():124407. PubMed ID: 38955239 [TBL] [Abstract][Full Text] [Related]
15. 3D printing of high drug loaded dosage forms using thermoplastic polyurethanes. Verstraete G; Samaro A; Grymonpré W; Vanhoorne V; Van Snick B; Boone MN; Hellemans T; Van Hoorebeke L; Remon JP; Vervaet C Int J Pharm; 2018 Jan; 536(1):318-325. PubMed ID: 29217471 [TBL] [Abstract][Full Text] [Related]
16. Fabrication of an osmotic 3D printed solid dosage form for controlled release of active pharmaceutical ingredients. Gioumouxouzis CI; Tzimtzimis E; Katsamenis OL; Dourou A; Markopoulou C; Bouropoulos N; Tzetzis D; Fatouros DG Eur J Pharm Sci; 2020 Feb; 143():105176. PubMed ID: 31809907 [TBL] [Abstract][Full Text] [Related]
17. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS. Oladeji S; Mohylyuk V; Jones DS; Andrews GP Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354 [TBL] [Abstract][Full Text] [Related]
18. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance. Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957 [TBL] [Abstract][Full Text] [Related]
19. Hot Melt Extrusion and its Application in 3D Printing of Pharmaceuticals. Deshkar S; Rathi M; Zambad S; Gandhi K Curr Drug Deliv; 2021; 18(4):387-407. PubMed ID: 33176646 [TBL] [Abstract][Full Text] [Related]
20. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs. Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]